ID   WBPE_PSEAE              Reviewed;         359 AA.
AC   Q9HZ76; P72136;
DT   03-OCT-2012, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   07-JAN-2015, entry version 74.
DE   RecName: Full=UDP-2-acetamido-2-deoxy-3-oxo-D-glucuronate aminotransferase;
DE            Short=UDP-3-oxo-D-GlcNAcA aminotransferase;
DE            EC=2.6.1.98;
DE   AltName: Full=UDP-2-acetamido-2-deoxy-alpha-D-ribo-hex-3-uluronic acid transaminase;
DE   AltName: Full=UDP-2-acetamido-2-deoxy-ribo-hexuluronate aminotransferase {ECO:0000303|PubMed:19282284};
GN   Name=wbpE {ECO:0000312|EMBL:AAG06543.1}; OrderedLocusNames=PA3155;
OS   Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG
OS   12228).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=208964;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAC45856.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND PATHWAY.
RC   STRAIN=ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228
RC   {ECO:0000312|EMBL:AAC45856.1};
RX   PubMed=8939432; DOI=10.1046/j.1365-2958.1996.1351503.x;
RA   Burrows L.L., Charter D.F., Lam J.S.;
RT   "Molecular characterization of the Pseudomonas aeruginosa serotype O5
RT   (PAO1) B-band lipopolysaccharide gene cluster.";
RL   Mol. Microbiol. 22:481-495(1996).
RN   [2] {ECO:0000312|EMBL:AAG06543.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228;
RX   PubMed=10984043; DOI=10.1038/35023079;
RA   Stover C.K., Pham X.-Q.T., Erwin A.L., Mizoguchi S.D., Warrener P.,
RA   Hickey M.J., Brinkman F.S.L., Hufnagle W.O., Kowalik D.J., Lagrou M.,
RA   Garber R.L., Goltry L., Tolentino E., Westbrock-Wadman S., Yuan Y.,
RA   Brody L.L., Coulter S.N., Folger K.R., Kas A., Larbig K., Lim R.M.,
RA   Smith K.A., Spencer D.H., Wong G.K.-S., Wu Z., Paulsen I.T.,
RA   Reizer J., Saier M.H. Jr., Hancock R.E.W., Lory S., Olson M.V.;
RT   "Complete genome sequence of Pseudomonas aeruginosa PAO1, an
RT   opportunistic pathogen.";
RL   Nature 406:959-964(2000).
RN   [3] {ECO:0000305}
RP   FUNCTION, AND PATHWAY.
RC   STRAIN=ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228
RC   {ECO:0000269|PubMed:18621892};
RX   PubMed=18621892; DOI=10.1128/JB.00579-08;
RA   Westman E.L., Preston A., Field R.A., Lam J.S.;
RT   "Biosynthesis of a rare di-N-acetylated sugar in the
RT   lipopolysaccharides of both Pseudomonas aeruginosa and Bordetella
RT   pertussis occurs via an identical scheme despite different gene
RT   clusters.";
RL   J. Bacteriol. 190:6060-6069(2008).
RN   [4] {ECO:0000305}
RP   FUNCTION, CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY, COFACTOR,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND PATHWAY.
RC   STRAIN=ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228
RC   {ECO:0000269|PubMed:19348502};
RX   PubMed=19348502; DOI=10.1021/bi900186u;
RA   Larkin A., Imperiali B.;
RT   "Biosynthesis of UDP-GlcNAc(3NAc)A by WbpB, WbpE, and WbpD: enzymes in
RT   the Wbp pathway responsible for O-antigen assembly in Pseudomonas
RT   aeruginosa PAO1.";
RL   Biochemistry 48:5446-5455(2009).
RN   [5] {ECO:0000305}
RP   FUNCTION, CATALYTIC ACTIVITY, AND PATHWAY.
RC   STRAIN=ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228
RC   {ECO:0000269|PubMed:19282284};
RX   PubMed=19282284; DOI=10.1074/jbc.M808583200;
RA   Westman E.L., McNally D.J., Charchoglyan A., Brewer D., Field R.A.,
RA   Lam J.S.;
RT   "Characterization of WbpB, WbpE, and WbpD and reconstitution of a
RT   pathway for the biosynthesis of UDP-2,3-diacetamido-2,3-dideoxy-D-
RT   mannuronic acid in Pseudomonas aeruginosa.";
RL   J. Biol. Chem. 284:11854-11862(2009).
RN   [6] {ECO:0000305, ECO:0000312|PDB:3NU7}
RP   X-RAY CRYSTALLOGRAPHY (1.50 ANGSTROMS) IN COMPLEXES WITH PYRIDOXAL
RP   PHOSPHATE; PYRIDOXAMINE PHOSPHATE AND THE EXTERNAL ALDIMINE OF PLP
RP   WITH NUCLEOTIDE SUGAR PRODUCT, COFACTOR, MUTAGENESIS OF THR-60;
RP   ASP-156; GLN-159; SER-180; LYS-185; ASN-227; ARG-229; HIS-308 AND
RP   TYR-309, AND SUBUNIT.
RC   STRAIN=ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228
RC   {ECO:0000269|PubMed:20604544};
RX   PubMed=20604544; DOI=10.1021/bi100805b;
RA   Larkin A., Olivier N.B., Imperiali B.;
RT   "Structural analysis of WbpE from Pseudomonas aeruginosa PAO1: a
RT   nucleotide sugar aminotransferase involved in O-antigen assembly.";
RL   Biochemistry 49:7227-7237(2010).
RN   [7] {ECO:0000312|PDB:3NYU}
RP   X-RAY CRYSTALLOGRAPHY (1.50 ANGSTROMS) IN COMPLEX WITH PYRIDOXAL
RP   PHOSPHATE.
RA   Holden H.M., Thoden J.B.;
RT   "X-ray crystal structure of the Wbpe (WlbE) aminotransferase from
RT   Pseudomonas aeruginosa as the PLP internal aldimine adduct with lysine
RT   185.";
RL   Submitted (JUL-2010) to the PDB data bank.
RN   [8] {ECO:0000312|PDB:3NYU}
RP   X-RAY CRYSTALLOGRAPHY (1.30 ANGSTROMS) OF MUTANT ALA-185 IN COMPLEX
RP   WITH THE EXTERNAL ALDIMINE OF PLP WITH NUCLEOTIDE SUGAR PRODUCT.
RA   Holden H.M., Thoden J.B.;
RT   "X-ray crystal structure of the WlbE (WpbE) aminotransferase from
RT   Pseudomonas aeruginosa, mutation K185A, in complex with the PLP
RT   external aldimine adduct with UDP-3-amino-2-N-acetyl-glucuronic acid,
RT   at 1.3 angstrom resolution.";
RL   Submitted (JUL-2010) to the PDB data bank.
RN   [9] {ECO:0000312|PDB:3NYU}
RP   X-RAY CRYSTALLOGRAPHY (1.45 ANGSTROMS) OF MUTANT ALA-185 IN COMPLEX
RP   WITH PYRIDOXAL PHOSPHATE.
RA   Holden H.M., Thoden J.B.;
RT   "X-ray structure of the K185A mutant of WbpE (WlbE) from Pseudomonas
RT   aeruginosa in complex with PLP at 1.45 angstrom resolution.";
RL   Submitted (JUL-2010) to the PDB data bank.
CC   -!- FUNCTION: Plays a role in the biosynthesis of B-band O antigen for
CC       serotype O5. Catalyzes the amination of UDP-2-acetamido-2-deoxy-3-
CC       oxo-D-glucuronic acid (UDP-3-oxo-D-GlcNAcA) to UDP-2-acetamido-3-
CC       amino-2,3-dideoxy-D-glucuronic acid (UDP-GlcNAc3NA), using L-
CC       glutamate as the preferred amine donor.
CC       {ECO:0000269|PubMed:18621892, ECO:0000269|PubMed:19282284,
CC       ECO:0000269|PubMed:19348502}.
CC   -!- CATALYTIC ACTIVITY: UDP-2-acetamido-3-amino-2,3-dideoxy-alpha-D-
CC       glucuronate + 2-oxoglutarate = UDP-2-acetamido-2-deoxy-D-ribo-hex-
CC       3-uluronate + L-glutamate. {ECO:0000269|PubMed:19282284,
CC       ECO:0000269|PubMed:19348502}.
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC         Evidence={ECO:0000269|PubMed:19348502,
CC         ECO:0000269|PubMed:20604544};
CC       Note=Binds 1 pyridoxal phosphate per subunit.
CC       {ECO:0000269|PubMed:19348502, ECO:0000269|PubMed:20604544};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimum pH is 8.0 for the coupled WbpB/WbpE reaction.
CC         {ECO:0000269|PubMed:19348502};
CC       Temperature dependence:
CC         Optimum temperature is 30 degrees Celsius for the coupled
CC         WbpB/WbpE reaction. {ECO:0000269|PubMed:19348502};
CC   -!- PATHWAY: Bacterial outer membrane biogenesis; LPS O-antigen
CC       biosynthesis. {ECO:0000269|PubMed:18621892,
CC       ECO:0000269|PubMed:19282284, ECO:0000269|PubMed:19348502,
CC       ECO:0000269|PubMed:8939432}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:20604544,
CC       ECO:0000269|Ref.7, ECO:0000269|Ref.8, ECO:0000269|Ref.9}.
CC   -!- SIMILARITY: Belongs to the DegT/DnrJ/EryC1 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC45856.1; Type=Frameshift; Positions=274; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U50396; AAC45856.1; ALT_FRAME; Genomic_DNA.
DR   EMBL; AE004091; AAG06543.1; -; Genomic_DNA.
DR   PIR; E83251; E83251.
DR   RefSeq; NP_251845.1; NC_002516.2.
DR   PDB; 3NU7; X-ray; 1.95 A; A/B=1-359.
DR   PDB; 3NU8; X-ray; 1.50 A; A/B=1-359.
DR   PDB; 3NUB; X-ray; 1.90 A; A/B=1-359.
DR   PDB; 3NYS; X-ray; 1.45 A; A=1-359.
DR   PDB; 3NYT; X-ray; 1.30 A; A=1-359.
DR   PDB; 3NYU; X-ray; 1.50 A; A/B/C/D=1-359.
DR   PDBsum; 3NU7; -.
DR   PDBsum; 3NU8; -.
DR   PDBsum; 3NUB; -.
DR   PDBsum; 3NYS; -.
DR   PDBsum; 3NYT; -.
DR   PDBsum; 3NYU; -.
DR   ProteinModelPortal; Q9HZ76; -.
DR   SMR; Q9HZ76; 1-359.
DR   STRING; 208964.PA3155; -.
DR   DNASU; 882653; -.
DR   EnsemblBacteria; AAG06543; AAG06543; PA3155.
DR   GeneID; 882653; -.
DR   KEGG; pae:PA3155; -.
DR   PATRIC; 19840877; VBIPseAer58763_3299.
DR   PseudoCAP; PA3155; -.
DR   HOGENOM; HOG000230164; -.
DR   InParanoid; Q9HZ76; -.
DR   KO; K13017; -.
DR   OMA; SCNSGTD; -.
DR   OrthoDB; EOG6TXQZ2; -.
DR   PhylomeDB; Q9HZ76; -.
DR   BioCyc; MetaCyc:MONOMER-17574; -.
DR   UniPathway; UPA00281; -.
DR   EvolutionaryTrace; Q9HZ76; -.
DR   Proteomes; UP000002438; Chromosome.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro.
DR   GO; GO:0008483; F:transaminase activity; IEA:UniProtKB-KW.
DR   GO; GO:0071555; P:cell wall organization; IEA:UniProtKB-KW.
DR   GO; GO:0009243; P:O antigen biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0000271; P:polysaccharide biosynthetic process; IDA:PseudoCAP.
DR   Gene3D; 3.40.640.10; -; 1.
DR   Gene3D; 3.90.1150.10; -; 1.
DR   InterPro; IPR000653; DegT/StrS_aminotransferase.
DR   InterPro; IPR015424; PyrdxlP-dep_Trfase.
DR   InterPro; IPR015421; PyrdxlP-dep_Trfase_major_sub1.
DR   InterPro; IPR015422; PyrdxlP-dep_Trfase_major_sub2.
DR   Pfam; PF01041; DegT_DnrJ_EryC1; 1.
DR   PIRSF; PIRSF000390; PLP_StrS; 1.
DR   SUPFAM; SSF53383; SSF53383; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Aminotransferase; Cell wall biogenesis/degradation;
KW   Complete proteome; Lipopolysaccharide biosynthesis;
KW   Pyridoxal phosphate; Reference proteome; Transferase.
FT   CHAIN         1    359       UDP-2-acetamido-2-deoxy-3-oxo-D-
FT                                glucuronate aminotransferase.
FT                                /FTId=PRO_0000419620.
FT   REGION       29     31       Nucleotide sugar substrate binding.
FT   REGION      308    309       Nucleotide sugar substrate binding.
FT   BINDING     184    184       Nucleotide sugar substrate.
FT   BINDING     229    229       Nucleotide sugar substrate.
FT   MOD_RES     185    185       N6-(pyridoxal phosphate)lysine.
FT                                {ECO:0000269|PubMed:20604544}.
FT   MUTAGEN      60     60       T->A: Minimal loss of activity.
FT                                {ECO:0000269|PubMed:20604544}.
FT   MUTAGEN     156    156       D->A: Minimal loss of activity.
FT                                {ECO:0000269|PubMed:20604544}.
FT   MUTAGEN     159    159       Q->A: Minimal loss of activity.
FT                                {ECO:0000269|PubMed:20604544}.
FT   MUTAGEN     180    180       S->A: Minimal loss of activity.
FT                                {ECO:0000269|PubMed:20604544}.
FT   MUTAGEN     185    185       K->A: Abolishes catalytic activity.
FT                                {ECO:0000269|PubMed:20604544}.
FT   MUTAGEN     227    227       N->A: Minimal loss of activity.
FT                                {ECO:0000269|PubMed:20604544}.
FT   MUTAGEN     229    229       R->A: Minimal loss of activity.
FT                                {ECO:0000269|PubMed:20604544}.
FT   MUTAGEN     308    308       H->A: Minimal loss of activity.
FT                                {ECO:0000269|PubMed:20604544}.
FT   MUTAGEN     309    309       Y->A: Minimal loss of activity.
FT                                {ECO:0000269|PubMed:20604544}.
FT   CONFLICT    276    276       N -> D (in Ref. 1; AAC45856).
FT                                {ECO:0000305}.
FT   HELIX         8     28       {ECO:0000244|PDB:3NYT}.
FT   HELIX        35     48       {ECO:0000244|PDB:3NYT}.
FT   STRAND       51     57       {ECO:0000244|PDB:3NYT}.
FT   HELIX        59     69       {ECO:0000244|PDB:3NYT}.
FT   STRAND       77     84       {ECO:0000244|PDB:3NYT}.
FT   HELIX        87     94       {ECO:0000244|PDB:3NYT}.
FT   STRAND       98    102       {ECO:0000244|PDB:3NYT}.
FT   TURN        106    108       {ECO:0000244|PDB:3NYT}.
FT   HELIX       113    115       {ECO:0000244|PDB:3NYT}.
FT   HELIX       117    119       {ECO:0000244|PDB:3NYT}.
FT   STRAND      124    127       {ECO:0000244|PDB:3NYT}.
FT   HELIX       132    134       {ECO:0000244|PDB:3NYT}.
FT   HELIX       139    148       {ECO:0000244|PDB:3NYT}.
FT   STRAND      153    156       {ECO:0000244|PDB:3NYT}.
FT   TURN        158    162       {ECO:0000244|PDB:3NYT}.
FT   STRAND      172    180       {ECO:0000244|PDB:3NYT}.
FT   STRAND      185    187       {ECO:0000244|PDB:3NYT}.
FT   STRAND      194    199       {ECO:0000244|PDB:3NYT}.
FT   HELIX       201    210       {ECO:0000244|PDB:3NYT}.
FT   STRAND      215    217       {ECO:0000244|PDB:3NYT}.
FT   HELIX       232    243       {ECO:0000244|PDB:3NYT}.
FT   HELIX       245    265       {ECO:0000244|PDB:3NYT}.
FT   STRAND      282    287       {ECO:0000244|PDB:3NYT}.
FT   HELIX       291    301       {ECO:0000244|PDB:3NYT}.
FT   HELIX       313    315       {ECO:0000244|PDB:3NYT}.
FT   HELIX       317    319       {ECO:0000244|PDB:3NYT}.
FT   STRAND      322    324       {ECO:0000244|PDB:3NYS}.
FT   HELIX       327    335       {ECO:0000244|PDB:3NYT}.
FT   STRAND      336    339       {ECO:0000244|PDB:3NYT}.
FT   HELIX       347    358       {ECO:0000244|PDB:3NYT}.
SQ   SEQUENCE   359 AA;  38925 MW;  A7466AC204A45815 CRC64;
     MIEFIDLKNQ QARIKDKIDA GIQRVLRHGQ YILGPEVTEL EDRLADFVGA KYCISCANGT
     DALQIVQMAL GVGPGDEVIT PGFTYVATAE TVALLGAKPV YVDIDPRTYN LDPQLLEAAI
     TPRTKAIIPV SLYGQCADFD AINAIASKYG IPVIEDAAQS FGASYKGKRS CNLSTVACTS
     FFPSKPLGCY GDGGAIFTND DELATAIRQI ARHGQDRRYH HIRVGVNSRL DTLQAAILLP
     KLEIFEEEIA LRQKVAAEYD LSLKQVGIGT PFIEVNNISV YAQYTVRMDN RESVQASLKA
     AGVPTAVHYP IPLNKQPAVA DEKAKLPVGD KAATQVMSLP MHPYLDTASI KIICAALTN
//
